Works matching Doxorubicin

Results: 5000

Investigation of the apoptotic and cell cycle effects of sorafenib and doxorubicin on URG4/URGCP in leukemia cells.

Published in:

Pamukkale Medical Journal, 2024, v. 17, n. 3, p. 498, doi. 10.31362/patd.1476105

By:

Dodurga, Yavuz;
Elmas, Levent;
Seçme, Mücahit;
Demirkıran, Nazlı;
Avcı, Çığır Biray;
Bağcı, Gülseren;
Sağ, Sevda;
Tufan, Lale Şatıroğlu

Publication type:

Article

Cardiotoxicity of Doxorubicin: Causes, Diagnosis, Consequences and Possibilities of Prevention.

Published in:

Hospital Pharmacology: International Multidisciplinary Journal, 2022, v. 9, n. 1, p. 1143, doi. 10.5937/hpimj2201143R

By:

Radić, Jelena P.;
Kolarov Bjelobrk, Ivana N.;
Stefanović, Maja Z.;
Bosanac, Milana M.;
Cvetković, Biljana R.;
Janičić, Stefan D.;
Dolamić, Borislav E.;
Ćuk, Dragomir R.;
Andrejić Višnjić, Bojana M.

Publication type:

Article

Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albuminbinding prodrug of the anticancer agent doxorubicin.

Published in:

Human & Experimental Toxicology, 2007, v. 26, n. 1, p. 19, doi. 10.1177/0960327107073825

By:

Kratz, F.;
Ehling, G.;
Kauffmann, H.-M.;
Unger, C.

Publication type:

Article

Effect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma: a randomized trial of pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine.

Published in:

2001

By:

Osoba, David;
Northfelt, Donald W.;
Budd, David W.;
Himmelberger, David;
Osoba, D;
Northfelt, D W;
Budd, D W;
Himmelberger, D

Publication type:

journal article

载阿霉素自组装多肽水凝胶的制备及体外评价.

Published in:

Chinese Journal of Tissue Engineering Research / Zhongguo Zuzhi Gongcheng Yanjiu, 2021, v. 25, n. 16, p. 2488, doi. 10.3969/j.issn.2095-4344.3114

By:

张馨;
陆莹;
姚庆强;
朱颐申

Publication type:

Article

Clinical consequences of the Calypso trial showing superiority of PEG-liposomal doxorubicin and carboplatin over paclitaxel and carboplatin in recurrent ovarian cancer: Results of an Austrian gynecologic oncologists' expert meeting.

Published in:

Wiener Klinische Wochenschrift, 2010, v. 122, n. 21/22, p. 649, doi. 10.1007/s00508-010-1483-1

By:

Petru, Edgar;
Reinthaller, Alexander;
Angleitner-Boubenizek, Lukas;
Schauer, Christian;
Zeimet, Alain;
Dirschlmayer, Wolfgang;
Medl, Michael;
Stummvoll, Wolfgang;
Sevelda, Paul;
Marth, Christian

Publication type:

Article

MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1.

Published in:

Biotechnology Letters, 2015, v. 37, n. 12, p. 2387, doi. 10.1007/s10529-015-1941-y

By:

Lu, Lin;
Ju, Fang;
Zhao, Hui;
Ma, Xuezhen

Publication type:

Article

Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1173, doi. 10.1007/s00280-010-1406-x

By:

Mamidi, Rao N. V. S.;
Weng, Steve;
Stellar, Susan;
Wang, Charles;
Ning Yu;
Huang, Tony;
Tonelli, Alfred P.;
Kelley, Michael F.;
Angiuoli, Anthony;
Man-Cheong Fung

Publication type:

Article

Indomethacin overcomes doxorubicin resistance by decreasing intracellular content of glutathione and its conjugates with decreasing expression of γ-glutamylcysteine synthetase via promoter activity in doxorubicin-resistant leukemia cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 4, p. 715, doi. 10.1007/s00280-008-0920-6

By:

Asano, Takeshi;
Tsutsuda-Asano, Arisa;
Fukunaga, Yoshitaka

Publication type:

Article

Pegylated Liposomal Doxorubicin (Caelyx®) in Metastatic Breast Cancer: A Community-Based Observation Study.

Published in:

Oncology, 2007, v. 72, n. 3/4, p. 147, doi. 10.1159/000112731

By:

Salzberg, Marc;
Thürlimann, Beat;
Hasler, Ursula;
Delmore, Geoffrey;
Von Rohr, Albert;
Thürlimann, Annatina;
Ruhstaller, Thomas;
Stopatschinskaja, Shanna;
Von Moos, Roger

Publication type:

Article

An Antisense Oligodeoxynucleotide-Doxorubicin Conjugate: Preparation and Its Reversal Multidrug Resistance of Human Carcinoma Cell Line In Vitro.

Published in:

Nucleosides, Nucleotides & Nucleic Acids, 2004, v. 23, n. 10, p. 1595, doi. 10.1081/NCN-200031419

By:

Ren, Yuhong;
Wei, Dongzhi;
Liu, Jianwen;
Su, Wu

Publication type:

Article

Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas.

Published in:

Cancers, 2023, v. 15, n. 20, p. 5036, doi. 10.3390/cancers15205036

By:

Buonadonna, Angela;
Scalone, Simona;
Lombardi, Davide;
Fumagalli, Arianna;
Guglielmi, Alessandra;
Lestuzzi, Chiara;
Polesel, Jerry;
Canzonieri, Vincenzo;
Lamon, Stefano;
Giovanis, Petros;
Gagno, Sara;
Corona, Giuseppe;
Mascarin, Maurizio;
Belluco, Claudio;
De Paoli, Antonino;
Fasola, Gianpiero;
Puglisi, Fabio;
Miolo, Gianmaria

Publication type:

Article

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia.

Published in:

Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01199-8

By:

Zeng, Yunxin;
Zhang, Xinyu;
Lin, Dongjun;
Feng, Xiaohui;
Liu, Yuye;
Fang, Zhengwen;
Zhang, Weijian;
Chen, Yu;
Zhao, Meng;
Wu, Jun;
Jiang, Linjia

Publication type:

Article

Pharmacokinetics (PK) of a liposomal encapsulated fraction containing doxorubicin and of doxorubicin released from the liposomal capsule after intravenous infusion of Caelyx™/Doxil®.

Published in:

International Journal of Clinical Pharmacology & Therapeutics, 2005, v. 43, n. 12, p. 588, doi. 10.5414/CPP43588

By:

Hilger, R. A.;
Richly, H.;
Grubert, M.;
Oberhoff, C.;
Strumberg, D.;
Scheulen, M. E.;
Seeber, S.

Publication type:

Article

Balancing efficacy and safety of doxorubicin-loaded albumin nanoparticles utilizing pH-sensitive doxorubicin-fatty acid prodrugs.

Published in:

Nano Research, 2024, v. 17, n. 6, p. 5491, doi. 10.1007/s12274-024-6533-5

By:

Yu, Yuanhao;
Zuo, Shiyi;
Song, Jiaxuan;
Li, Lingxiao;
Liu, Tian;
Guo, Jiayu;
Li, Yaqiao;
Wang, Danping;
Lu, Qi;
Wang, Helin;
Zhou, Dun;
He, Zhonggui;
Liu, Xiaohong;
Sun, Bingjun;
Sun, Jin

Publication type:

Article

Biodistribution and preclinical safety profile of legubicin: A novel conjugate of doxorubicin and a legumain‐cleavable peptide linker.

Published in:

Journal of Applied Toxicology, 2024, v. 44, n. 9, p. 1426, doi. 10.1002/jat.4622

By:

Wang, Yan;
Wei, Liping;
Liu, Yuan;
Liu, Cheng;
Hou, Minbo;
Zhou, Lu;
Wang, Le;
Li, Hua;
Qiu, Yunliang;
JingMa

Publication type:

Article

Combined doxorubicin and arctigenin treatment induce cell cycle arrest‐associated cell death by promoting doxorubicin uptake in doxorubicin‐resistant breast cancer cells.

Published in:

IUBMB Life, 2023, v. 75, n. 9, p. 765, doi. 10.1002/iub.2772

By:

Lee, Min‐Gu;
Lee, Kyu‐Shik;
Nam, Kyung‐Soo

Publication type:

Article

Replacement of conventional doxorubicin by pegylated liposomal doxorubicin is a safe and effective alternative in the treatment of non-Hodgkin's lymphoma patients with cardiac risk factors.

Published in:

Annals of Hematology, 2012, v. 91, n. 3, p. 391, doi. 10.1007/s00277-011-1308-y

By:

Schmitt, Christian;
Dietrich, Sascha;
Ho, Antony;
Witzens-Harig, Mathias

Publication type:

Article

Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in vitro.

Published in:

Oncology Letters, 2018, v. 15, n. 4, p. 4635, doi. 10.3892/ol.2018.7887

By:

Buschauer, Sebastian;
Koch, Andreas;
Wiggermann, Philipp;
Müller, Martina;
Hellerbrand, Claus

Publication type:

Article

The Power and Potential of Doxorubicin-DNA Adducts.

Published in:

IUBMB Life, 2005, v. 57, n. 2, p. 73, doi. 10.1080/15216540500079093

By:

Cutts, Suzanne;
Nudelman, Abraham;
Rephaeli, Ada;
Phillips, Don R.

Publication type:

Article

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Published in:

2020

By:

D'Ambrosio, Lorenzo;
Touati, Nathan;
Blay, Jean‐Yves;
Grignani, Giovanni;
Flippot, Ronan;
Czarnecka, Anna M.;
Piperno‐Neumann, Sophie;
Martin‐Broto, Javier;
Sanfilippo, Roberta;
Katz, Daniela;
Duffaud, Florence;
Vincenzi, Bruno;
Stark, Daniel P.;
Mazzeo, Filomena;
Tuchscherer, Armin;
Chevreau, Christine;
Sherriff, Jenny;
Estival, Anna;
Litière, Saskia;
Sents, Ward

Publication type:

journal article

Thermosensitive liposomal doxorubicin plus radiofrequency ablation increased tumor destruction and improved survival in patients with medium and large hepatocellular carcinoma: A randomized, double-blinded, dummy-controlled clinical trial in a single center.

Published in:

2019

By:

Yang, Wei;
Lee, Jung-Chieh;
Chen, Min-Hua;
Zhang, Zhong-Yi;
Bai, Xiu-Mei;
Yin, Shan-Shan;
Cao, Kun;
Wang, Song;
Wu, Wei;
Yan, Kun

Publication type:

journal article

Comparative plasma and tissue distribution of Sun Pharma's generic doxorubicin HCl liposome injection versus Caelyx<sup>®</sup> (doxorubicin HCl liposome injection) in syngeneic fibrosarcoma-bearing BALB/c mice and Sprague-Dawley rats.

Published in:

2017

By:

Burade, Vinod;
Bhowmick, Subhas;
Maiti, Kuntal;
Zalawadia, Rishit;
Jain, Deepak;
Rajamannar, Thennati

Publication type:

journal article

High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with Tc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 211, doi. 10.1007/s00280-014-2477-x

By:

Arrieta, Oscar;
Medina, Luis-Alberto;
Estrada-Lobato, Enrique;
Ramírez-Tirado, Laura-Alejandra;
Mendoza-García, Víctor-Osvaldo;
de la Garza-Salazar, Jaime

Publication type:

Article

Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma.

Published in:

Cellular & Molecular Life Sciences, 2019, v. 76, n. 3, p. 609, doi. 10.1007/s00018-018-2967-9

By:

Buondonno, Ilaria;
Gazzano, Elena;
Tavanti, Elisa;
Chegaev, Konstantin;
Kopecka, Joanna;
Fanelli, Marilù;
Rolando, Barbara;
Fruttero, Roberta;
Gasco, Alberto;
Hattinger, Claudia;
Serra, Massimo;
Riganti, Chiara

Publication type:

Article

Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization.

Published in:

BMC Cancer, 2012, v. 12, n. 1, p. 381, doi. 10.1186/1471-2407-12-381

By:

Heibein, Allan D.;
Guo, Baoqing;
Sprowl, Jason A.;
MacLean, David A.;
Parissenti, Amadeo M.

Publication type:

Article

Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction.

Published in:

European Journal of Heart Failure, 2014, v. 16, n. 4, p. 358, doi. 10.1002/ejhf.50

By:

Tocchetti, Carlo G.;
Carpi, Andrea;
Coppola, Carmela;
Quintavalle, Cristina;
Rea, Domenica;
Campesan, Marika;
Arcari, Antonella;
Piscopo, Giovanna;
Cipresso, Clemente;
Monti, Maria Gaia;
De Lorenzo, Claudia;
Arra, Claudio;
Condorelli, Gerolama;
Di Lisa, Fabio;
Maurea, Nicola

Publication type:

Article

The efficacy and hyperthermic release of doxorubicin from liposomal doxorubicin hydrochloride in rabbit VX2 tumours.

Published in:

International Journal of Hyperthermia, 2015, v. 31, n. 8, p. 900, doi. 10.3109/02656736.2015.1078502

By:

Xiong, Ping;
Ding, Angang;
Su, Zhiqiang;
Shen, Guofeng;
Chen, Yazhu;
Zhang, Su

Publication type:

Article

Comparison of active and passive targeting of doxorubicin for somatostatin receptor 2 positive tumor models by octreotide-modified HPMA copolymer-doxorubicin conjugates.

Published in:

Drug Delivery, 2016, v. 23, n. 1, p. 285, doi. 10.3109/10717544.2014.911991

By:

He, Shuang;
Zhou, Zhou;
Li, Lian;
Yang, Qingqing;
Yang, Yang;
Guan, Shan;
Zhang, Jian;
Zhu, Xi;
Jin, Yun;
Huang, Yuan

Publication type:

Article

Erythropoietin Hormone and ACE Inhibitor Protect the Sperm Parameters of Adult Male Rats Against Doxorubicin Toxicity.

Published in:

Kafkas Universitesi Veteriner Fakultesi Dergisi, 2015, v. 21, n. 6, p. 805, doi. 10.9775/kvfd.2015.13412

By:

AKMAN, Orhan;
ÖZKANLAR, Yunusemre;
ÖZKANLAR, Seçkin;
ORUÇ, Ertan;
ULAŞ, Nergis;
ZİYPAK, Tevfik;
LEHİMCİOĞLU, Necdet Cankat;
TÜRKELİ, Mehmet;
UÇAR, Ömer

Publication type:

Article

The Innate Immune System in Cardiovascular Diseases and Its Role in Doxorubicin-Induced Cardiotoxicity.

Published in:

2022

By:

Bhagat, Anchit;
Shrestha, Pradeep;
Kleinerman, Eugenie S.

Publication type:

Literature Review

Cell-Penetrating Doxorubicin Released from Elastin-Like Polypeptide Kills Doxorubicin-Resistant Cancer Cells in In Vitro Study.

Published in:

International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1126, doi. 10.3390/ijms22031126

By:

Ryu, Jung Su;
Kratz, Felix;
Raucher, Drazen;
Stefanachi, Angela

Publication type:

Article

Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin.

Published in:

International Journal of Molecular Sciences, 2019, v. 20, n. 15, p. 3696, doi. 10.3390/ijms20153696

By:

Alshaer, Walhan;
Alqudah, Dana A.;
Wehaibi, Suha;
Abuarqoub, Duaa;
Zihlif, Malek;
Hatmal, Ma'mon M.;
Awidi, Abdalla

Publication type:

Article

Combination of Doxorubicin and Sulforaphane for Reversing Doxorubicin-Resistant Phenotype in Mouse Fibroblasts with p53<sup>Ser220</sup> Mutation.

Published in:

Annals of the New York Academy of Sciences, 2007, v. 1095, n. 1, p. 62, doi. 10.1196/annals.1397.008

By:

FIMOGNARI, CARMELA;
LENZI, MONIA;
SCIUSCIO, DAVIDE;
CANTELLI‐FORTI, GIORGIO;
HRELIA, PATRIZIA

Publication type:

Article

Doxorubicin or Epirubicin Versus Liposomal Doxorubicin Therapy—Differences in Cardiotoxicity.

Published in:

Cardiovascular Toxicology, 2025, v. 25, n. 2, p. 248, doi. 10.1007/s12012-024-09952-4

By:

Buchalska, Barbara;
Kamińska, Katarzyna;
Kowara, Michał;
Sobiborowicz-Sadowska, Aleksandra;
Cudnoch-Jędrzejewska, Agnieszka

Publication type:

Article

Doxorubicin and Liposomal Doxorubicin Differentially Affect Expression of miR-208a and let-7g in Rat Ventricles and Atria.

Published in:

Cardiovascular Toxicology, 2017, v. 17, n. 3, p. 355, doi. 10.1007/s12012-016-9393-8

By:

Novak, Jan;
Sana, Jiri;
Stracina, Tibor;
Novakova, Marie;
Slaby, Ondrej

Publication type:

Article

Anticancer Potential of Pyridoxine-Based Doxorubicin Derivatives: An In Vitro Study.

Published in:

Life (2075-1729), 2024, v. 14, n. 3, p. 282, doi. 10.3390/life14030282

By:

Karwt, Rawdah;
Bondar, Oksana V.;
Pugachev, Mikhail V.;
Mohammad, Tharaa;
Kadyrova, Aisylu S.;
Pavelyev, Roman S.;
Alrhmoun, Saleh;
Gnezdilov, Oleg I.;
Shtyrlin, Yurii G.

Publication type:

Article

Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells.

Published in:

Frontiers in Pharmacology, 2019, v. 10, p. 1, doi. 10.3389/fphar.2019.01434

By:

Wang, Xu;
Hui, Renjie;
Chen, Yun;
Wang, Wentao;
Chen, Yujiao;
Gong, Xiaohai;
Jin, Jian

Publication type:

Article

Bevacizumab in combination with oxaliplatin and doxorubicin or liposomal doxorubicin for hepatocellular cancer: A case series.

Published in:

Asia Pacific Journal of Clinical Oncology, 2011, v. 7, n. 2, p. 174, doi. 10.1111/j.1743-7563.2010.01345.x

By:

KU, Geoffrey Y.;
DE LIMA LOPES Jr, Gilberto;
CHANG, Alex Y.

Publication type:

Article

Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma.

Published in:

Veterinary & Comparative Oncology, 2017, v. 15, n. 1, p. 25, doi. 10.1111/vco.12139

By:

Finotello, R.;
Stefanello, D.;
Zini, E.;
Marconato, L.

Publication type:

Article

Safety of concurrent administration of dexrazoxane and doxorubicin in the canine cancer patient Safety of concurrent administration of dexrazoxane and doxorubicin in the canine cancer patient W. M. FitzPatrick et al.

Published in:

Veterinary & Comparative Oncology, 2010, v. 8, n. 4, p. 273, doi. 10.1111/j.1476-5829.2010.00225.x

By:

FitzPatrick, W. M.;
Dervisis, N. G.;
Kitchell, B. E.

Publication type:

Article

Self-assembled nanoparticles from folate-decorated maleilated pullulan-doxorubicin conjugate for improved drug delivery to cancer cells.

Published in:

Polymer International, 2013, v. 62, n. 2, p. 165, doi. 10.1002/pi.4272

By:

Li, Fei;
Zhang, Haitao;
Gu, Chunhu;
Fan, Li;
Qiao, Youbei;
Tao, Yangchun;
Cheng, Chong;
Wu, Hong;
Yi, Jun

Publication type:

Article

Effect of Doxorubicin on Telomerase Activity and Apoptotic Gene Expression in Doxorubicin-Resistant and -Sensitive MCF-7 Cells.

Published in:

Chemotherapy (0009-3157), 2008, v. 54, n. 3, p. 209, doi. 10.1159/000140464

By:

Eskiocak, Uğur;
İşeri, Ozlem Darcansoy;
Kars, Meltem Demirel;
Biçer, Atilla;
Gunduz, Ufuk

Publication type:

Article

Double Encapsulation of Resveratrol and Doxorubicin in Composite Nanogel—An Opportunity to Reduce Cardio- and Neurotoxicity of Doxorubicin.

Published in:

Gels (2310-2861), 2024, v. 10, n. 11, p. 699, doi. 10.3390/gels10110699

By:

Radeva, Lyubomira;
Yordanov, Yordan;
Spassova, Ivanka;
Kovacheva, Daniela;
Tzankova, Virginia;
Yoncheva, Krassimira

Publication type:

Article

Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies.

Published in:

Pharmaceutics, 2023, v. 15, n. 7, p. 1920, doi. 10.3390/pharmaceutics15071920

By:

Dorostkar, Hamidreza;
Haghiralsadat, Bibi Fatemeh;
Hemati, Mahdie;
Safari, Fatemeh;
Hassanpour, Azam;
Naghib, Seyed Morteza;
Roozbahani, Mohammad Hossein;
Mozafari, M. R.;
Moradi, Ali

Publication type:

Article

Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells.

Published in:

Pharmaceutics, 2019, v. 11, n. 2, p. 63, doi. 10.3390/pharmaceutics11020063

By:

Soe, Zar Chi;
Kwon, Jun Bum;
Thapa, Raj Kumar;
Ou, Wenquan;
Nguyen, Hanh Thuy;
Gautam, Milan;
Oh, Kyung Taek;
Choi, Han-Gon;
Ku, Sae Kwang;
Yong, Chul Soon;
Kim, Jong Oh

Publication type:

Article

Application of Optical Methods for Determination of Concentration of Doxorubicin in Blood and Plasma.

Published in:

Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 112, doi. 10.3390/ph15020112

By:

Sikora, Tomasz;
Morawska, Karolina;
Lisowski, Wiesław;
Rytel, Paweł;
Dylong, Agnieszka

Publication type:

Article

Proanthocyanidin from grape seeds enhances doxorubicin-induced antitumor effect and reverses drug resistance in doxorubicin-resistant K562/DOX cells.

Published in:

Canadian Journal of Physiology & Pharmacology, 2005, v. 83, n. 3, p. 309, doi. 10.1139/Y05-018

By:

Xiao-Yu Zhang;
Wen-Guang Li;
Yong-Jie Wu;
De-Cheng Bai;
Nai-Fa Liu

Publication type:

Article

Anti-tumor and anti-metastatic effects of gelatin-doxorubicin and PEGylated gelatin-doxorubicin nanoparticles in SCC7 bearing mice.

Published in:

Journal of Drug Targeting, 2006, v. 14, n. 10, p. 707, doi. 10.1080/10611860600935701

By:

Young Lee, Gee;
Park, Kyeongsoon;
Nam, Jong Hee;
Kim, Sang Yoon;
Byun, Youngro

Publication type:

Article

Facile fabrication of a novel hybrid nanoparticles by self-assembling based on pectin-doxorubicin conjugates for hepatocellular carcinoma therapy.

Published in:

Artificial Cells, Nanomedicine & Biotechnology, 2018, v. 46, p. S661, doi. 10.1080/21691401.2018.1505745

By:

Ye, Peng-Ju;
Huang, Can;
Yang, Sa;
Gao, Pei;
Li, Zhi-Ping;
Tang, Si-Yue;
Xiang, Ya;
Liu, Yu-Feng;
Chen, Yu-Ping;
He, Dong-Xiu;
Yu, Cui-Yun

Publication type:

Article